205 related articles for article (PubMed ID: 28127569)
1. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
[TBL] [Abstract][Full Text] [Related]
2. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
3. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani A; Al-Ahdal M; Abdo A; Sanai F; Al-Anazi M; Khalaf N; Viswan NA; Al-Ashgar H; Al-Humaidan H; Al-Suwayeh R; Hussain Z; Alarifi S; Al-Okail M; Almajhdi FN
J Med Virol; 2012 Sep; 84(9):1353-9. PubMed ID: 22825813
[TBL] [Abstract][Full Text] [Related]
5. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
6. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
[TBL] [Abstract][Full Text] [Related]
7. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
[TBL] [Abstract][Full Text] [Related]
8. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
11. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
[TBL] [Abstract][Full Text] [Related]
12. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
[TBL] [Abstract][Full Text] [Related]
13. The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection.
El-Bendary M; Neamatallah M; Elalfy H; Besheer T; Elkholi A; El-Diasty M; Elsareef M; Zahran M; El-Aarag B; Gomaa A; Elhammady D; El-Setouhy M; Hegazy A; Esmat G
Br J Biomed Sci; 2018 Oct; 75(4):175-181. PubMed ID: 29947302
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
15. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
16. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
Lee SO; Brown RA; Razonable RR
Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 gene polymorphisms are not associated with the risk of hepatitis B and hepatitis C virus infection.
Sá KS; Pires-Neto Ode S; Santana BB; Gomes ST; Amoras Eda S; Conde SR; Demachki S; Azevedo VN; Machado LF; Martins-Feitosa RN; Ishak Mde O; Ishak R; Vallinoto AC
Rev Soc Bras Med Trop; 2015; 48(2):136-42. PubMed ID: 25992926
[TBL] [Abstract][Full Text] [Related]
18. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
[TBL] [Abstract][Full Text] [Related]
19. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
[TBL] [Abstract][Full Text] [Related]
20. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
